中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Author Name	Affiliation	E-mail
GUO Zhi-jun
LI Chun-sheng	Emergency Department of Beijing Chaoyang Hospital, Capital Medical University, Beijing (100020), China	lcscyyy@163.com

Hits: 1233

Download times: 1181

Abstract:

Survival rates after cardiac arrest have not changed substantially over the past 5 decades. Post-cardiac arrest (CA) syndrome (PCAS) is the primary reason for the high mortality rate after successful restoration of spontaneous circulation (ROSC). Intravenous administration of Shenfu Injection (参附注射液, SFI) may attenuate post-CA myocardial dysfunction and cerebral injury, inhibit systemic ischemia/reperfusion responses, and treat underlying diseases. In this article, we reviewed the therapeutic effects of SFI in PCAS. SFI might be useful in the treatment of PCAS, incorporating the multi-link and multi-target advantages of Chinese medicine into PCAS management. Further experimental and clinical research to verify the therapeutic effects of SFI in PCAS is required.